Transforming DNA Methylation Analysis with Next-Generation Bisulfite Conversion
Developed in Professor Chuan He’s lab at the University of Chicago, Ellis Bio is advancing the field of epigenetics with next-generation bisulfite conversion technology. Their SuperMethyl™ platform is designed to overcome the limitations of the current kits on the market, delivering higher accuracy, speed, and reliability for today’s most demanding applications.
What makes Ellis Bio different?
-
SuperMethyl™ Max – High DNA recovery, even from low-input and cfDNA samples (100 pg–50 ng)
-
SuperMethyl™ Fast – Complete bisulfite conversion in under 10 minutes
-
Exceptional Conversion Efficiency – >99.5% C-to-T conversion rate
-
Enhanced Accuracy – Reliable results for methylation-based biomarker discovery
These Research Use Only (RUO) kits are purpose-built to support both clinical and basic research workflows, enabling breakthroughs in cancer biology, biomarker development, and liquid biopsy applications.
Ellis Bio continues to empower researchers by providing tools that make epigenomic analysis more efficient, reproducible, and scalable.